XT
ACET icon

XTX Topco’s Adicet Bio ACET Stock Holding History

XTX Topco’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$130K Buy
19,126
+516
+3% +$3.86K ﹤0.01% 3014
2025
Q4 		$157K Buy
18,610
+14,976
+412% +$166K ﹤0.01% 2485
2025
Q3 		$47.1K Buy
3,634
+2,160
+147% +$25.4K ﹤0.01% 2185
2025
Q2 		$14.4K Buy
+1,474
New +$15.5K ﹤0.01% 2209
2025
Q1 		– Sell
-4,262
Closed -$65.6K – 2336
2024
Q4 		$65.6K Sell
4,262
-13,999
-77% -$264K 0.01% 1851
2024
Q3 		$421K Buy
18,261
+2,024
+12% +$45.3K 0.03% 938
2024
Q2 		$314K Buy
16,237
+2,109
+15% +$56.5K 0.03% 927
2024
Q1 		$531K Buy
14,128
+12,690
+882% +$525K 0.07% 451
2023
Q4 		$43.5K Sell
1,438
-2,038
-59% -$44.4K 0.01% 1252
2023
Q3 		$76.2K Buy
3,476
+841
+32% +$29.7K 0.01% 1218
2023
Q2 		$102K Buy
2,635
+1,940
+279% +$171K 0.02% 1160
2023
Q1 		$64K Sell
695
-1,143
-62% -$143K 0.01% 1146
2022
Q4 		$263K Buy
+1,838
New +$459K 0.06% 682

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

XTX Topco's ACET Position: Q1 2026 in Review

XTX Topco increased its Adicet Bio (ACET) stake by 2.8% in Q1 2026, buying an estimated $3.86K and bringing the position to 19,126 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #3014.

XTX Topco first reported a position in ACET in Q4 2022 and has held it in 13 quarters since. The position peaked at $531K in Q1 2024. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • XTX Topco held 19,126 shares of Adicet Bio worth $130K as of Q1 2026.
  • XTX Topco bought 516 Adicet Bio shares in Q1 2026, an estimated $3.86K.
  • Adicet Bio made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3014 holding.
  • XTX Topco first reported a position in Adicet Bio in Q4 2022 and has held it in 13 quarters since.
  • XTX Topco's Adicet Bio position peaked at $531K in Q1 2024.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.